Nothing Special   »   [go: up one dir, main page]

Bagnasco et al., 1988 - Google Patents

Graves' disease: phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroid

Bagnasco et al., 1988

Document ID
7606398078528401007
Author
Bagnasco M
Venuti D
Prigione I
Torre G
Ferrini S
Canonica G
Publication year
Publication venue
Clinical immunology and immunopathology

External Links

Snippet

We have investigated at the clonal level the repertoire of intrathyroid and peripheral T lymphocytes in three patients with Graves' disease using a high efficiency cloning technique. Clonal efficiencies ranged from 10 to 31% for intrathyroid, and from 19 to 100% for …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0636T lymphocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Similar Documents

Publication Publication Date Title
MacKenzie et al. Intrathyroidal T cell clones from patients with autoimmune thyroid disease
Balch et al. Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients
Damle et al. Immunoregulatory T lymphocytes in man. Soluble antigen-specific suppressor-inducer T lymphocytes are derived from the CD4+ CD45R-p80+ subpopulation.
EP0025722B1 (en) Monoclonal antibody to human cytotoxic and suppressor t cells, and method of preparing it
JACKSON et al. Ia+ T cells in new onset Graves' disease
EP0017381A2 (en) Monoclonal antibody to human T cells, method for preparing it, hybrid cell line producing it, therapeutic composition comprising it and diagnostic method using it
Eguchi et al. Increment in the Ta1+ cells in the peripheral blood and thyroid tissue of patients with Graves' disease.
Lederman et al. Defective suppressor cell generation in juvenile onset diabetes.
Pawelec et al. Acquisition of suppressive activity and natural killer-like cytotoxicity by human alloproliferative" helper" T cell clones.
Douglas Petersen et al. Autoreactive and immunoregulatory T-cell subsets in insulindependent diabetes mellitus
Bagnasco et al. Graves' disease: phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroid
REINsMoEN et al. DIFFERENTIATION OF CLASS I-AND CLASS II-DIRECTED DONOR-SPECIFIC ALLOREACTIVITY IN BRONCHOALVEOLAR LAVAGE LYMPHOCYTES FROM LUNG TRANSPLANT RECIPIENTS1
Pawelec et al. Restimulation properties of human alloreactive cloned T-cell lines. Dissection of HLA-D-region alleles in population studies and in family segregation analysis
Gorczynski et al. Suppression of Cytotoxic Response to Histoincompatible Cells: I. Evidence for Two Types of T Lymphocyte-Derived Suppressors Acting at Different Stages in the Induction of a Cytotoxic Response
Andrews et al. The limited immunocompetence of thymocytes within murine thymic nurse cells
Ballas et al. Lymphokine-activated killer (LAK) cells. III. Characterization of LAK precursors and susceptible target cells within the murine thymus.
Engleman et al. Functional characteristics of human T-cell subpopulations distinguished by a monoclonal antibody
Stevenson et al. Characterization of purified cryopreserved human monocyte function in assays of superoxide production, accessory cell function, chemotaxis, and in fluorescent cell sorter analysis
Sarawar et al. T-cell receptor-bearing cells from athymic nude rats respond to alloantigen in vitro but are defective in vivo.
HAMMERSTRØM Human adherent mononuclear blood cells: Cytolytic and cytostatic activity and characterization of effector cells during in vitro culture
Domingo et al. Human pregnancy serum inhibits proliferation of T8-depleted cells and their interleukin-2 synthesis in mixed lymphocyte cultures
Plata et al. Characterization of Effector Lymphocytes Associated with Immunity to Murine Sarcoma Virus (MSV) Induced Tumors: I. Physical Properties of Cytolytic T Lymphocytes Generated in Vitro and of Their Immediate Progenitors
Romagnani et al. Clonal analysis of T lymphocytes in spleens from patients with Hodgkin's disease. Frequent occurrence of unusual T4‐positive cells which co‐express cytolytic activity and production of interleukin‐2
Canonica et al. Autoimmune thyroid disease: purification and phenotypic analysis of intrathyroid T cells
EP0939796B1 (en) Uses of oncofetal antigen specific cd4, cd8 cytotoxic and suppressor t cells and interleukin-10